Cambridge biotech opts for Nasdaq listing over LSE’s AIM
September 13, 2022 at 04:24 AM EDT
Life sciences research tool supplier Abcam said it will seek to delist from the AIM on London’s stock exchange following a “positive shareholder response”.
